Christopher C. Rider

Author

Royal Holloway University of London ORCID

Also Known As

C C Rider, C. C. Rider, C.C Rider, C.C. RIDER, C.C. Rider, CHRISTOPHER C. RIDER, Chaley Rider, Christopher C Rider, Christopher C. Rider, Christopher Rider

Publications

2.7K

Citations

H-Index

116

Concepts

All Affiliations

Royal Holloway University of London University of Sheffield University of Oxford University of Portsmouth National Institute for Biological Standards and Control

About

Christopher C. Rider is an author at Royal Holloway University of London specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	28	1.2K
2	Natural Sciences	5	5	231
3	Public Health	3	3	47
4	Engineering	1	1	41
5	Health Sciences	1	1	17

Christopher C. Rider

Publications

Citations

H-Index

Page 1

	Year	Citations
Enolase isoenzymes in rat tissues: Electrophoretic, chromatographic, immunological and kinetic properties Christopher C. Rider, C. Barr Taylor Biochimica et Biophysica Acta (BBA) - Protein Structure Kinetic PropertiesBiochemistryBioanalysisPhysiologyRat Tissues	1974	193
Enolase isoenzymes Lynne Fletcher, Christopher C. Rider, C. Barr Taylor Biochimica et Biophysica Acta (BBA) - Enzymology	1976	180
Characterization of the Heparin-Binding Properties of IL-6 Rosemary S. Mummery, Christopher C. Rider The Journal of Immunology	2000	169
Selective and differential binding of interleukin (IL)‐1α, IL‐1β, IL‐2 and IL‐6 to glycosaminoglycans Lawrence Ramsden, Christopher C. Rider European Journal of Immunology	1992	121
IL-12 Is a Heparin-Binding Cytokine Maemunah Hasan, Saloua Najjam, Myrtle Y. Gordon, The Journal of Immunology ImmunologyGlycobiologyImmune SystemImmunotherapyHeparin-binding Cytokine	1999	110
CHARACTERIZATION OF HUMAN RECOMBINANT INTERLEUKIN 2 BINDING TO HEPARIN AND HEPARAN SULFATE USING AN ELISA APPROACH Saloua Najjam, Roslyn V. Gibbs, Myrtle Y. Gordon, Cytokine InflammationCytokineAutoimmune DiseaseLaboratory ImmunologyImmunology	1997	95
Evidence for a new form of enolase in rat brain Christopher C. Rider, C. Barr Taylor Biochemical and Biophysical Research Communications Molecular NeuroscienceNew FormNeurophysiologyNeuroanatomyPhysiology	1975	87
Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4 Hilary A. Harrop, Christopher C. Rider Glycobiology MedicineHuman RetrovirusImmunologyGlycobiologyDirect Radiolabel	1998	74
Anti-HIV-1 Activity of Chemically Modified Heparins: Correlation between Binding to the V3 Loop of gp120 and Inhibition of Cellular HIV-1 Infection in vitro Christopher C. Rider, Deirdre R. Coombe, Hilary A. Harrop, Biochemistry	1994	72
Enolase isoenzymes as markers of differentiation in teratocarcinoma cells and normal tissues of mouse Lynne Fletcher, Christopher C. Rider, C. Barr Taylor, Developmental Biology Teratocarcinoma CellsNormal TissuesPathologyGene ExpressionMedicine	1978	71

Page 1